| 发明名称 |
ERYTHROPOIETIN VARIANTS |
| 摘要 |
The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammation, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.
|
| 申请公布号 |
US2011008363(A1) |
申请公布日期 |
2011.01.13 |
| 申请号 |
US20080334995 |
申请日期 |
2008.12.15 |
| 申请人 |
MEISEL ANDREAS;PRILLER JOSEF;BONNAS CHRISTEL;DIRNAGL ULRICH |
发明人 |
MEISEL ANDREAS;PRILLER JOSEF;BONNAS CHRISTEL;DIRNAGL ULRICH |
| 分类号 |
A61K39/395;A01K67/033;A61K31/7088;A61K35/12;A61K38/18;A61P9/10;C07H21/04;C07K14/505;C07K16/18;C12N5/10;C12N15/63;C12P21/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
